发明申请
US20050043345A1 Pharmaceutical composition for the prevention and treatment of addiction in a mammal
审中-公开
用于预防和治疗哺乳动物成瘾的药物组合物
- 专利标题： Pharmaceutical composition for the prevention and treatment of addiction in a mammal
- 专利标题（中）： 用于预防和治疗哺乳动物成瘾的药物组合物
-
申请号： US10870821申请日： 2004-06-17
-
公开(公告)号： US20050043345A1公开(公告)日： 2005-02-24
- 发明人: Jotham Coe , Philip Iredale , Stanton McHardy , Stafford McLean
- 申请人： Jotham Coe , Philip Iredale , Stanton McHardy , Stafford McLean
- 专利权人： Pfizer Inc
- 当前专利权人： Pfizer Inc
- 主分类号： A61K31/18
- IPC分类号： A61K31/18 ; A61K31/197 ; A61K31/33 ; A61K31/407 ; A61K31/4745 ; A61K45/06
摘要：
Pharmaceutical compositions are disclosed for the treatment of alcohol or cocaine dependence or addiction, tobacco dependence or addiction, reduction of alcohol withdrawal symptoms or aiding in the cessation or lessening of alcohol use or substance abuse or other behavioral dependencies including gambling. The pharmaceutical compositions are comprised of a therapeutically effective combination of an opioid receptor antagonist and an alpha2delta ligand and a pharmaceutically acceptable carrier. The method of using these compounds is also disclosed.
信息查询
